Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you offer hypofractionation or RNI for a pT1N0 high-grade primary neuroendocrine carcinoma of the breast?
Answer from: Radiation Oncologist at Community Practice
Hypofractionation with a boost, yes. No RNI if the SNLN is negative.
Sign In
or
Register
to read more
30923
Related Questions
Does pre-chemotherapy extent of nodal involvement impact your decision to offer adjuvant radiation in cN1, ypN0 triple-negative breast cancer?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
Does a high genomic risk score impact your radiation fields for patients with breast cancer?
Would you offer prone APBI with IMRT/VMAT?
How do you weigh upfront nodal burden when deciding to omit PMRT in a patient with cN1, ypN0 disease after neoadjuvant chemo, mastectomy and ALND?
What is your approach to women with breast cancer who opts for a staged approach with up-front lumpectomy and SLN biopsy (pN-) when there are indications for adjuvant radiation therapy but she plans for a later mastectomy (=>6 months)?
Would you offer PMRT to a patient with pTisN1a left breast DCIS?
Is re-excision of residual disease ever itself an indication for PMRT?
What are your top takeaways in Radiation Oncology from SABCS 2025?